Oragenics Management
Management criteria checks 2/4
Oragenics' CEO is Janet Huffman, appointed in Mar 2023, has a tenure of 1.75 years. total yearly compensation is $365.40K, comprised of 57% salary and 43% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth $5.67K. The average tenure of the management team and the board of directors is 0.8 years and 13.7 years respectively.
Key information
Janet Huffman
Chief executive officer
US$365.4k
Total compensation
| CEO salary percentage | 57.0% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.1% |
| Management average tenure | less than a year |
| Board average tenure | 13.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$20m |
| Jun 30 2024 | n/a | n/a | -US$20m |
| Mar 31 2024 | n/a | n/a | -US$20m |
| Dec 31 2023 | US$365k | US$208k | -US$21m |
Compensation vs Market: Janet's total compensation ($USD365.40K) is about average for companies of similar size in the UK market ($USD345.77K).
Compensation vs Earnings: Insufficient data to compare Janet's compensation with company performance.
CEO
Janet Huffman (52 yo)
1.8yrs
Tenure
US$365,396
Compensation
Ms. Janet Huffman serves as Interim Principal Executive Officer and President of Oragenics, Inc. from December 16, 2024. Mr. Huffman serves as Chief Financial Officer and Secretary at Oragenics, Inc. since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 14.5yrs | US$196.75k | 0.21% $ 9.6k | |
| President | 1.8yrs | US$365.40k | 0.12% $ 5.7k | |
| Chief Medical Officer & Member of Scientific Advisor | less than a year | no data | no data | |
| Chief Clinical Officer | less than a year | no data | no data |
0.8yrs
Average Tenure
Experienced Management: 0A64's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 14.5yrs | US$196.75k | 0.21% $ 9.6k | |
| Chief Medical Officer & Member of Scientific Advisor | less than a year | no data | no data | |
| Independent Director | 1.2yrs | US$25.13k | 0% $ 0 | |
| Independent Director | 14.5yrs | US$156.75k | 0.28% $ 13.1k | |
| Independent Director | 13.7yrs | US$140.50k | 0.21% $ 9.7k | |
| Independent Director | 1.2yrs | US$25.13k | 2.9% $ 134.0k | |
| Independent Director | 15.5yrs | US$134.25k | 0.23% $ 10.6k | |
| Member of Scientific Advisor | no data | no data | no data | |
| Member of Scientific Advisor | no data | no data | no data | |
| Member of Scientific Advisor | no data | no data | no data |
13.7yrs
Average Tenure
71yo
Average Age
Experienced Board: 0A64's board of directors are seasoned and experienced ( 13.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:57 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oragenics, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Theodore O'Neill | Ascendiant Capital Markets LLC |
| Keith Markey | Griffin Securities |